My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 506

    1.

    A low-sodium diet potentiates the effects of losartan in type 2 diabetes.

    Houlihan CA, Allen TJ, Baxter AL, Panangiotopoulos S, Casley DJ, Cooper ME, Jerums G.

    Diabetes Care. 2002 Apr;25(4):663-71.PMID: 11919122 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction.

    Houlihan CA, Akdeniz A, Tsalamandris C, Cooper ME, Jerums G, Gilbert RE.

    Diabetes Care. 2002 Jun;25(6):1072-7.PMID: 12032117 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.

    Mülhauser I, Prange K, Sawicki PT, Bender R, Dworschak A, Schaden W, Berger M.

    Diabetologia. 1996 Feb;39(2):212-9.PMID: 8635674 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy.

    Yasuda G, Ando D, Hirawa N, Umemura S, Tochikubo O.

    Diabetes Care. 2005 Aug;28(8):1862-8.PMID: 16043724 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.

    Chan JC, Nicholls MG, Cheung CK, Law LK, Swaminathan R, Cockram CS.

    Diabetes Care. 1995 Jul;18(7):1001-6.PMID: 7555530 [PubMed - indexed for MEDLINE]Related articles

    6.

    Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.

    Burnier M, Rutschmann B, Nussberger J, Versaggi J, Shahinfar S, Waeber B, Brunner HR.

    Hypertension. 1993 Sep;22(3):339-47.PMID: 8349327 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.

    Andersen S, Jacobsen P, Tarnow L, Rossing P, Juhl TR, Parving HH.

    Nephrol Dial Transplant. 2003 Feb;18(2):293-7.PMID: 12543883 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance.

    Vedovato M, Lepore G, Coracina A, Dodesini AR, Jori E, Tiengo A, Del Prato S, Trevisan R.

    Diabetologia. 2004 Feb;47(2):300-3. Epub 2003 Dec 24.PMID: 14704836 [PubMed - indexed for MEDLINE]Related articles

    9.

    Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

    de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM.

    Kidney Int. 2004 Jun;65(6):2309-20.PMID: 15149345 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study]

    Goicolea I, Fernández González R, Piniés J, Garrido J, Martínez JM, Armenteros S, Moreno Carretero E.

    Nefrologia. 2002;22(2):170-8. Spanish. PMID: 12085418 [PubMed - indexed for MEDLINE]Related articles

    11.

    Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

    Diabetes Care. 2003 May;26(5):1501-6.PMID: 12716812 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.

    Vervoort G, Hertenberg F, Wetzels JF, Smits P.

    J Hypertens. 1998 Feb;16(2):245-50.PMID: 9535153 [PubMed - indexed for MEDLINE]Related articles

    13.

    Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.

    Garcia R, Bonhomme MC, Diebold S.

    J Hypertens. 1996 Jan;14(1):81-9.PMID: 12013499 [PubMed - indexed for MEDLINE]Related articles

    14.

    Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

    Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH.

    Diabetologia. 2004 Nov;47(11):1936-9. Epub 2004 Nov 17.PMID: 15551047 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker.

    Uzu T, Sakaguchi M, Yokomaku Y, Kume S, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Koya D, Haneda M, Kashiwagi A.

    Clin Exp Nephrol. 2009 Aug;13(4):300-6. Epub 2009 Mar 3. Erratum in: Clin Exp Nephrol. 2009 Aug;13(4):307. PMID: 19255824 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria.

    Esmatjes E, Flores L, Iñigo P, Lario S, Ruilope LM, Campistol JM.

    Nephrol Dial Transplant. 2001;16 Suppl 1:90-3.PMID: 11369831 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.

    Dodson PM, Beevers M, Hallworth R, Webberley MJ, Fletcher RF, Taylor KG.

    BMJ. 1989 Jan 28;298(6668):227-30.PMID: 2493869 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Losartan titration versus diuretic combination in type 2 diabetic patients.

    de Pablos-Velasco PL, Pazos Toral F, Esmatjes JE, Fernandez-Vega F, Lopez de la Torre ML, Pozuelo A, Ruilope LM.

    J Hypertens. 2002 Apr;20(4):715-9.PMID: 11910308 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.

    Tan KC, Chow WS, Ai VH, Lam KS.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):71-6.PMID: 11921421 [PubMed - indexed for MEDLINE]Related articles

    20.

    The IGF-I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial.

    Zandbergen AA, Lamberts SW, Baggen MG, Janssen JA, Boersma E, Bootsma AH.

    Clin Endocrinol (Oxf). 2006 Feb;64(2):203-8.PMID: 16430721 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity